GSK Warns of Label Tampering on HIV Medications

Washington Drug Letter
KEYWORDS FDA / labeling
A A

A third party tampered with the labels on two GlaxoSmithKline (GSK) HIV infection medications, placing incorrect and counterfeit labels on the products, the company and the FDA announced.

To View This Article:

Login

Buy This Article Now

Add this article to your cart for $10.00